Delivery Order SPE2DB20D1100-SPE2DB25FD6N1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of CellCept 500 mg tablets (100-count units) valued at $7,015.33. This firm fixed-price delivery order, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $3,611.49 delivery order to AmerisourceBergen Drug Corp for CellCept 500 mg tablets (100-count) under a firm fixed-price contract. The award was issued on September 15, 2025, with an ultimate completion date of September 16, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order contract award from the Defense Logistics Agency's Medical Supply Chain for the supply of CellCept 500 mg tablets (500-count bottles). The contract, awarded May 12, 2025, carries a firm fixed price ceiling value of $8,316.17 with an ultimate completion date of May 13, 2025. This delivery order represents a non-set-aside, competitively awarded procurement and is classified as a child contract under...
- The Defense Logistics Agency awarded a $29,003.35 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of CellCept 500 mg tablets (500-count units). This is a firm fixed price, non-set-aside contract with a completion date of August 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of CellCept 500 mg on August 25, 2025, with a ceiling value of $2,407.68 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 26, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 mg CellCept tablets (500-count units) valued at $44,285.82 with a firm fixed price structure. The delivery order, issued on September 25, 2025, with an ultimate completion date of September 26, 2025, represents a competitive award with no set-aside designation. Performance will be executed at the contractor's Conshohocken, Pennsylvania location, which serves as the company's corporate headquarters and...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on July 16, 2025, for CellCept 250 mg capsules (100-count units) with a ceiling value of $17,152.58. This firm fixed-price delivery order, which is due for completion by July 17, 2025, represents a non-set-aside competitive award under the broader pharmaceutical supply framework. The contract will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $15,369.82 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 tablets of CELLCEPT 500 MG. The order is to be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with performance spanning June 20-21, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the immunosuppressant drug to support DLA's medical supply chain requirements. No subcontractors...
- This is a $55,214.59 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for CELLCEPT 500 MG TABLET 500S. The contract has an ultimate completion date of June 17, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, providing a comprehensive global pharmaceutical support...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a for-profit organization and leading global pharmaceutical sourcing and distribution services company. The contract, valued at $46,855.96, is for the delivery of CELLCEPT 500 MG TABLET 100S to support military treatment programs and facilities. The delivery order has an ultimate completion date of March 20, 2024. AmerisourceBergen Drug Corporation holds an indefinite...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD6N1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,063.75 to AmerisourceBergen Drug Corp for 100 tablets of CellCept 500 mg, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under a larger contract vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including critical medications, vaccines, and specialized medical commodities. AmerisourceBergen's federal contract portfolio demonstrates its established capability as a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through multiple therapeutic domains and delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.1k | 7/25/25 |